American Well Corporation (AMWL)

$1.19

Market is closed - opens 7 PM, 25 Sep 2023

Insights on American Well Corporation

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 69.20M → 62.44M (in $), with an average decrease of 9.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -61.16M → -92.47M (in $), with an average decrease of 51.2% per quarter

  • Vs TXG

    In the last 1 year, 10x Genomics Inc has given 43.0% return, outperforming this stock by 109.4%

  • Vs RCM

    In the last 3 years, American Well Corporation has experienced a drawdown of -95.8%, however R1 Rcm Inc resisted the overall trend and outperformed by 30.2%

Performance

  • $1.17
    $1.22
    $1.19
    downward going graph

    1.68%

    Downside

    Day's Volatility :4.1%

    Upside

    2.46%

    downward going graph
  • $1.17
    $4.39
    $1.19
    downward going graph

    1.68%

    Downside

    52 Weeks Volatility :73.35%

    Upside

    72.89%

    downward going graph

Returns

PeriodAmerican Well CorporationSector (Health Care)Index (Russel 2000)
3 Months
-43.87%
-1.4%
0.0%
6 Months
-46.88%
3.7%
2.8%
1 Year
-66.38%
6.0%
5.3%
3 Years
-95.82%
27.7%
21.9%

Highlights

Market Capitalization
424.2M
Book Value
$2.2
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.23
Wall Street Target Price
2.64
Profit Margin
-226.06%
Operating Margin TTM
-94.27%
Return On Assets TTM
-15.64%
Return On Equity TTM
-69.18%
Revenue TTM
274.9M
Revenue Per Share TTM
0.99
Quarterly Revenue Growth YOY
-3.2%
Gross Profit TTM
116.8M
EBITDA
-231.1M
Diluted Eps TTM
-2.23
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.01
EPS Estimate Next Year
-0.75
EPS Estimate Current Quarter
-0.22
EPS Estimate Next Quarter
-0.21

Analyst Recommendation

Hold
    38%Buy
    61%Hold
    0
    0%Sell
Based on 21 Wall street analysts offering stock ratings for American Well Corporation(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
13
13
13
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 121.85%

Current $1.19
Target $2.64

Company Financials

FY18Y/Y Change
Revenue
114.0M
-
Net Income
-52.7M
-
Net Profit Margin
-46.22%
-
FY19Y/Y Change
Revenue
148.9M
↑ 30.63%
Net Income
-87.2M
↑ 65.53%
Net Profit Margin
-58.57%
↓ 12.35%
FY20Y/Y Change
Revenue
245.3M
↑ 64.77%
Net Income
-224.4M
↑ 157.41%
Net Profit Margin
-91.51%
↓ 32.94%
FY21Y/Y Change
Revenue
252.8M
↑ 3.07%
Net Income
-176.3M
↓ 21.43%
Net Profit Margin
-69.76%
↑ 21.75%
Q1 FY22Q/Q Change
Revenue
64.2M
↓ 11.71%
Net Income
-70.0M
↑ 46.54%
Net Profit Margin
-109.04%
↓ 43.35%
Q2 FY22Q/Q Change
Revenue
64.5M
↑ 0.44%
Net Income
-69.1M
↓ 1.27%
Net Profit Margin
-107.17%
↑ 1.87%
Q3 FY22Q/Q Change
Revenue
69.2M
↑ 7.27%
Net Income
-70.1M
↑ 1.36%
Net Profit Margin
-101.26%
↑ 5.91%
Q2 FY23Q/Q Change
Revenue
62.4M
-
Net Income
-92.5M
-
Net Profit Margin
-148.09%
-
FY18Y/Y Change
Total Assets
489.3M
-
Total Liabilities
693.7M
-
FY19Y/Y Change
Total Assets
499.9M
↑ 2.16%
Total Liabilities
780.7M
↑ 12.54%
FY20Y/Y Change
Total Assets
1.4B
↑ 175.39%
Total Liabilities
130.4M
↓ 83.29%
FY21Y/Y Change
Total Assets
1.4B
↑ 5.03%
Total Liabilities
185.0M
↑ 41.79%
FY22Y/Y Change
Total Assets
1.2B
↓ 15.79%
Total Liabilities
133.7M
↓ 27.71%
Q1 FY22Q/Q Change
Total Assets
1.4B
↓ 5.81%
Total Liabilities
153.0M
↓ 17.27%
Q2 FY22Q/Q Change
Total Assets
1.3B
↓ 4.65%
Total Liabilities
137.6M
↓ 10.08%
Q3 FY22Q/Q Change
Total Assets
1.2B
↓ 5.14%
Total Liabilities
126.9M
↓ 7.74%
Q4 FY22Q/Q Change
Total Assets
1.2B
↓ 1.15%
Total Liabilities
133.7M
↑ 5.34%
Q1 FY23Q/Q Change
Total Assets
850.5M
↓ 30.15%
Total Liabilities
136.2M
↑ 1.89%
Q2 FY23Q/Q Change
Total Assets
772.2M
↓ 9.21%
Total Liabilities
128.5M
↓ 5.68%
FY18Y/Y Change
Operating Cash Flow
-74.0M
-
Investing Cash Flow
-245.9M
-
Financing Cash Flow
278.2M
-
FY19Y/Y Change
Operating Cash Flow
-81.9M
↑ 10.66%
Investing Cash Flow
120.0M
↓ 148.79%
Financing Cash Flow
46.6M
↓ 83.23%
FY20Y/Y Change
Operating Cash Flow
-112.5M
↑ 37.33%
Investing Cash Flow
-66.8M
↓ 155.63%
Financing Cash Flow
983.1M
↑ 2007.93%
FY21Y/Y Change
Operating Cash Flow
-141.5M
↑ 25.85%
Investing Cash Flow
-59.6M
↓ 10.67%
Financing Cash Flow
5.8M
↓ 99.41%
Q1 FY22Q/Q Change
Operating Cash Flow
-62.2M
↑ 38.44%
Investing Cash Flow
-499.3M
↑ 147619.23%
Financing Cash Flow
-7.8M
↓ 737.06%
Q2 FY22Q/Q Change
Operating Cash Flow
-43.2M
↓ 30.52%
Investing Cash Flow
123.0M
↓ 124.64%
Financing Cash Flow
2.2M
↓ 128.69%
Q3 FY22Q/Q Change
Operating Cash Flow
-51.0M
↑ 17.98%
Investing Cash Flow
124.9M
↑ 1.54%
Financing Cash Flow
1.5M
↓ 32.55%

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
American Well Corporation
American Well Corporation
-11.19%
-46.88%
-66.38%
-95.82%
-94.84%
R1 Rcm Inc
R1 Rcm Inc
-5.52%
13.31%
-17.17%
3.73%
59.96%
10x Genomics Inc
10x Genomics Inc
-13.37%
-15.68%
43.03%
-65.63%
-21.61%
Veeva Systems Inc.
Veeva Systems Inc.
8.28%
16.7%
24.96%
-24.92%
93.21%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-6.75%
-15.03%
6.35%
6.35%
6.35%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
American Well Corporation
American Well Corporation
NA
NA
NA
-2.01
-0.69
-0.16
0.0
2.2
R1 Rcm Inc
R1 Rcm Inc
128.18
NA
0.77
0.06
-0.02
0.02
0.0
6.55
10x Genomics Inc
10x Genomics Inc
NA
NA
NA
-1.69
-0.22
-0.11
0.0
6.76
Veeva Systems Inc.
Veeva Systems Inc.
61.02
61.02
1.27
4.18
0.15
0.05
0.0
25.85
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
19.51
19.51
NA
3.8
0.15
0.06
0.0
15.62
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
American Well Corporation
American Well Corporation
Hold
$424.2M
-94.84%
NA
-226.06%
R1 Rcm Inc
R1 Rcm Inc
Buy
$6.3B
59.96%
128.18
-3.09%
10x Genomics Inc
10x Genomics Inc
Buy
$6.3B
-21.61%
NA
-30.31%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.6B
93.21%
61.02
24.2%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$31.5B
6.35%
19.51
9.62%

Institutional Holdings

  • RIMA MANAGEMENT, LLC

    7.80%

  • Vanguard Group Inc

    7.71%

  • BlackRock Inc

    7.47%

  • Caledonia (Private) Investments Pty Ltd

    6.10%

  • SATTER MANAGEMENT CO., L.P.

    3.68%

  • State Street Corporation

    2.12%

Corporate Announcements

  • American Well Corporation Earnings

    American Well Corporation’s price-to-earnings ratio stands at None

    Read More

Company Information

amwell (previously known as american well) is a leading telehealth platform in the united states and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. amwell believes that digital care delivery will transform healthcare. the company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, behavioral health, as well as chronic care management and healthy living. with over a decade of experience, amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers, reaching over 80 million lives.

Organization
American Well Corporation
Employees
1123
CEO
Dr. Ido Schoenberg M.D.
Industry
Technology Services

Discover More

FAQs